Intercure (INCR) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.65, -0.85% vs the prior close of $4.69.
- Volume 6.10K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
INCR dips 0.9% to $4.65, a 1-month low. Closed at $4.65, -0.85% vs the prior close of $4.69. Day range $4.65β$4.94, opened at $4.81.
INCR daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β INCR dips 0.9% to $4.65, a 1-month low
- Closed at $4.65, -0.85% vs the prior close of $4.69. Day range $4.65β$4.94, opened at $4.81.
- Volume was 6.10K shares, 0.2x its 50-day average of 27.26K β lighter than usual.
- Price is -9.9% vs its 50-day average ($5.16) and +0.1% vs its 200-day average ($4.65).
- 52-week range $3.40β$8.10; today's close sits at 27% of that range, 42.6% below the 52-week high.
Oct 14, 2026 β INCR slides 6.8% to $4.69, a 1-month low
- Closed at $4.69, -6.76% vs the prior close of $5.03. Day range $4.67β$4.98, opened at $4.80.
- Volume was 9.50K shares, 0.4x its 50-day average of 27.09K β lighter than usual.
- Price is -9.2% vs its 50-day average ($5.17) and +0.9% vs its 200-day average ($4.65).
- 52-week range $3.40β$8.16; today's close sits at 27% of that range, 42.5% below the 52-week high.
Oct 13, 2026 β INCR rises 1.6% to $5.03
- Closed at $5.03, +1.62% vs the prior close of $4.95. Day range $4.86β$5.22, opened at $4.86.
- Volume was 6.90K shares, 0.3x its 50-day average of 26.98K β lighter than usual.
- Price is -2.7% vs its 50-day average ($5.17) and +8.1% vs its 200-day average ($4.65).
- 52-week range $3.40β$8.32; today's close sits at 33% of that range, 39.5% below the 52-week high.
Oct 12, 2026 β INCR slides 4.3% to $4.95, a 1-month low
- Closed at $4.95, -4.26% vs the prior close of $5.17. Day range $4.74β$5.45, opened at $5.03.
- Volume was 6.70K shares, 0.2x its 50-day average of 26.92K β lighter than usual.
- Price is -4.1% vs its 50-day average ($5.16) and +6.3% vs its 200-day average ($4.66).
- 52-week range $3.40β$8.40; today's close sits at 31% of that range, 41.1% below the 52-week high.
Oct 9, 2026 β INCR rises 2.8% to $5.17
- Closed at $5.17, +2.78% vs the prior close of $5.03. Day range $5.17β$5.17, opened at $5.17.
- Volume was 500 shares, 0.0x its 50-day average of 26.96K β lighter than usual.
- Price is +0.2% vs its 50-day average ($5.16) and +10.9% vs its 200-day average ($4.66).
- 52-week range $3.40β$8.45; today's close sits at 35% of that range, 38.8% below the 52-week high.
Oct 8, 2026 β INCR dips 1.9% to $5.03, a 1-month low, 3 down days in a row
- Closed at $5.03, -1.95% vs the prior close of $5.13. Day range $5.02β$5.12, opened at $5.10.
- Volume was 3.30K shares, 0.1x its 50-day average of 26.99K β lighter than usual.
- Price is -2.4% vs its 50-day average ($5.15) and +7.8% vs its 200-day average ($4.67).
- 52-week range $3.40β$8.45; today's close sits at 32% of that range, 40.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β INCR slides 3.6% to $5.13
- Closed at $5.13, -3.57% vs the prior close of $5.32. Day range $5.13β$5.34, opened at $5.32.
- Volume was 7.80K shares, 0.3x its 50-day average of 26.91K β lighter than usual.
- Price is -0.2% vs its 50-day average ($5.14) and +9.7% vs its 200-day average ($4.68).
- 52-week range $3.40β$8.45; today's close sits at 34% of that range, 39.3% below the 52-week high.
Oct 6, 2026 β INCR dips 2.4% to $5.32
- Closed at $5.32, -2.39% vs the prior close of $5.45. Day range $5.30β$5.32, opened at $5.30.
- Volume was 2.60K shares, 0.1x its 50-day average of 26.92K β lighter than usual.
- Price is +3.8% vs its 50-day average ($5.13) and +13.5% vs its 200-day average ($4.69).
- 52-week range $3.40β$8.45; today's close sits at 38% of that range, 37.0% below the 52-week high.
Oct 5, 2026 β INCR rises 0.6% to $5.45, 5 up days in a row
- Closed at $5.45, +0.55% vs the prior close of $5.42. Day range $5.45β$5.45, opened at $5.45.
- Volume was 1.50K shares, 0.1x its 50-day average of 26.94K β lighter than usual.
- Price is +6.6% vs its 50-day average ($5.11) and +16.1% vs its 200-day average ($4.70).
- 52-week range $3.40β$8.45; today's close sits at 41% of that range, 35.5% below the 52-week high.
- That makes 5 straight gains.
Oct 2, 2026 β INCR rises 0.9% to $5.42, 4 up days in a row
- Closed at $5.42, +0.93% vs the prior close of $5.37. Day range $5.38β$5.42, opened at $5.38.
- Volume was 2.80K shares, 0.1x its 50-day average of 26.99K β lighter than usual.
- Price is +6.3% vs its 50-day average ($5.10) and +15.2% vs its 200-day average ($4.70).
- 52-week range $3.40β$8.45; today's close sits at 40% of that range, 35.9% below the 52-week high.
- That makes 4 straight gains.
INCR latest news & SEC filings
Every SEC filing by or about INCR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 27, 2026 Β· Form 6-K/A β 6-K/A filing
6-K/A filing
Aug 26, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 24, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 11, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 4, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 27, 2026 Β· Form 6-K/A β 6-K/A filing
6-K/A filing
Jul 22, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 22, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade INCR
- How much it moves: over the last 20 sessions the average daily move was 2.18% (largest 6.8%).
- Liquidity: about 5.01K shares (β$23.32K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.65 vs a range of $3.40β$8.10 (27% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Aug 24, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 8, 2026; 6-K Aug 26, 2026; 6-K Aug 24, 2026.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
INCR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.81 | 4.94 | 4.65 | 4.65 | 6.10K |
| Oct 14, 2026 | 4.80 | 4.98 | 4.67 | 4.69 | 9.50K |
| Oct 13, 2026 | 4.86 | 5.22 | 4.86 | 5.03 | 6.90K |
| Oct 12, 2026 | 5.03 | 5.45 | 4.74 | 4.95 | 6.70K |
| Oct 9, 2026 | 5.17 | 5.17 | 5.17 | 5.17 | 500 |
| Oct 8, 2026 | 5.10 | 5.12 | 5.02 | 5.03 | 3.30K |
| Oct 7, 2026 | 5.32 | 5.34 | 5.13 | 5.13 | 7.80K |
| Oct 6, 2026 | 5.30 | 5.32 | 5.30 | 5.32 | 2.60K |
| Oct 5, 2026 | 5.45 | 5.45 | 5.45 | 5.45 | 1.50K |
| Oct 2, 2026 | 5.38 | 5.42 | 5.38 | 5.42 | 2.80K |
| Oct 1, 2026 | 5.43 | 5.48 | 5.37 | 5.37 | 2.00K |
| Sep 30, 2026 | 5.37 | 5.38 | 5.23 | 5.27 | 3.60K |
| Sep 29, 2026 | 5.10 | 5.33 | 5.10 | 5.23 | 2.30K |
| Sep 28, 2026 | 5.01 | 5.10 | 5.01 | 5.09 | 2.10K |
| Sep 25, 2026 | 5.10 | 5.26 | 5.02 | 5.21 | 8.90K |
| Sep 24, 2026 | 5.42 | 5.42 | 5.11 | 5.26 | 2.50K |
| Sep 23, 2026 | 5.38 | 5.47 | 5.25 | 5.47 | 5.20K |
| Sep 22, 2026 | 5.32 | 5.68 | 5.28 | 5.39 | 21.70K |
| Sep 21, 2026 | 5.24 | 5.24 | 5.24 | 5.24 | 500 |
| Sep 18, 2026 | 5.35 | 5.35 | 5.30 | 5.31 | 3.80K |
About Intercure
Intercure (INCR) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in HERZLIYA, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1857030.
INCR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alon Shmuel Granot | Director | Apr 20, 2026 |
| Gideon Hirschfeld | Director | Apr 16, 2026 |
| Lennie Grinbaum Michelson | Director | Apr 20, 2026 |
| Alexander Rabinovich | Chief Executive Officer | Apr 20, 2026 |
| David Salton | Director | Apr 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Amos Cohen | Chief Financial Officer | Aug 24, 2026 |
| Alexander Rabinovich | Chief Executive Officer | Apr 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
INCR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
INCR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on INCR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.